Meds A-Z
Furosemide
Detailed information about Furosemide
Veterinary professional?
Add to My Pet's Meds
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continueReviewed / Updated / Sources
Reviewed: Not available
Updated: February 12, 2026, 7:40 PM UTC
- FDA application profile · official_label
- FDA application profile · official_label
- Medication usage source · fda_animal_drugs
- Furos-A-Vet · official_label
- openFDA case USA-USFDACVM-2025-US-054506 · adverse_reaction
Pet Owner Quick Guide
Start here first for the simple next-step summary.
Used for:
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
What to watch for:
- Use caution with dehydration, kidney disease, or electrolyte imbalances
- wobbly/unsteady walking (1 reports)
- very low energy (1 reports)
- Not eating (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Safety & side effects
What to watch:
- Use caution with dehydration, kidney disease, or electrolyte imbalances
- wobbly/unsteady walking
- very low energy
- Not eating
Most reported reactions:
- Unsteady walking (ataxia) (1 reports)
- Tiredness (lethargy) (1 reports)
- Not eating (1 reports)
When to call your vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Data freshness: source data appears current.
Latest refresh: Mar 21, 2026, 10:01 a.m.
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 7:40 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 16, 2026, 10:03 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:19 AM UTC
Furosemide
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Intervet, Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200759 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/34478 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Use caution with dehydration, kidney disease, or electrolyte imbalances.
- High: Use caution with dehydration, kidney disease, or electrolyte imbalances.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Grouped by Body System
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Neurologic | 1 | Dog | 1 | |
| Neurologic | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Digestive | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Digestive | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (20) Cat (12)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Neurologic | Dog | Serious | - | 1 | |
| Neurologic | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Effectiveness | Dog | Serious | - | 1 | |
| Effectiveness | Dog | Non-serious | - | 1 | |
| Effectiveness | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Behavior | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-054506
Storage & Handling
Store at room temperature.
Documents
Owner handouts and official technical documents are grouped for faster access.
Owner handouts (0)
- No owner handouts linked yet.
Official label / PI (0)
- No official label or package insert links yet.
SPL (14)
-
Furosemide Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17546/Furosemide%20Tablets
-
Salix®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/386/Salix%C2%AE
-
Furos-A-Vet
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1509/Furos-A-Vet
-
Disal® Injection
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2122/Disal%C2%AE%20Injection
-
Disal®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2078/Disal%C2%AE
-
Disal®
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2046/Disal%C2%AE
-
Furosemide Injection 5%
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/98/Furosemide%20Injection%205%25
-
Furosemide Syrup 1%
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/112/Furosemide%20Syrup%201%25
-
Furosemide Syrup 1%
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/94/Furosemide%20Syrup%201%25
-
Furosemide Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2002/Furosemide%20Tablets
-
Furosemide Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2058/Furosemide%20Tablets
-
Lasix® Packets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/819/Lasix%C2%AE%20Packets
-
Lasix® Syrup 1%
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1609/Lasix%C2%AE%20Syrup%201%25
-
Salix® Tablets
· SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/391/Salix%C2%AE%20Tablets
FOI (4)
-
FOI Summary oA 200-759 Approved July 18, 2025.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17256
-
ucm061739.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1045
-
ucm059305.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1124
-
ucm061337.pdf
· FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1133
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17256 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17546/Furosemide%20Tablets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/386/Salix%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1509/Furos-A-Vet · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2122/Disal%C2%AE%20Injection · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2078/Disal%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2046/Disal%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1045 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/98/Furosemide%20Injection%205%25 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1124 · document · FOI
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 7:40 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Mar 16, 2026, 10:03 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:19 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Use caution with dehydration, kidney disease, or electrolyte imbalances. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-6737-01 | 0010 | - | |
| 0010-6738-01 | 0010 | - | |
| 0010-6739-01 | 0010 | - | |
| 11695-0090-5 | 11695 | - | |
| 11695-0091-5 | 11695 | - | |
| 11695-0092-1 | 11695 | - | |
| 11695-2222-2 | 11695 | - | |
| 13985-303-60 | 13985 | - | |
| 13985-581-10 | 13985 | - | |
| 13985-585-50 | 13985 | - | |
| 13985-586-12 | 13985 | - | |
| 57926-463-30 | 57926 | - | |
| 57926-464-31 | 57926 | - | |
| 57926-465-01 | 57926 | - | |
| 58829-303-60 | 58829 | - | |
| 73309-064-01 | 73309 | - | |
| 73309-064-02 | 73309 | - | |
| 73377-163-01 | 73377 | - | |
| 73377-163-03 | 73377 | - | |
| 86117-016-12 | 86117 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oA 200-759 Approved July 18, 2025.pdf
• FOI summary • Official
• July 31, 2025
FDA FOI summary for application 200759
-
ucm061337.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200382
-
ucm059305.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200373
-
ucm061739.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200293
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
- storage_handling: Store at room temperature. (Clinical, 2026-02-12)
- contraindications: Use caution with dehydration, kidney disease, or electrolyte imbalances. (Official, 2026-02-12)
- side_effects: Increased urination, dehydration, electrolyte changes. (Official, 2026-02-12)
- usage: Diuretic used to manage fluid overload (commonly in heart failure). (Official, 2026-02-12)
- side_effects updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Furosemide Tablets
RX
Furosemide
Tablet
• Oral
|
ZYVET AH, Inc. | ANADA 200-759 | Approved | Jul 31, 2025 |
|
Salix®
RX
Furosemide
Liquid (Solution)
• Intravenous, Intramuscular
|
Intervet, Inc. | NADA 34478 | Approved | Feb 25, 2025 |
|
Furos-A-Vet
RX
Furosemide
Liquid (Solution)
• Intramuscular, Intravenous
|
Bimeda Animal Health Limited | NADA 118-550 | Approved | Oct 2, 2018 |
|
Disal® Injection
RX
Furosemide
Liquid (Solution)
• Intramuscular, Intravenous
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 127-034 | Approved | Nov 13, 2017 |
|
Disal®
RX
Furosemide
Tablet
• Oral
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 129-034 | Approved | Jun 1, 2016 |
|
Disal®
RX
Furosemide
Liquid (Solution)
• Intravenous, Intramuscular
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 131-538 | Approved | Jun 1, 2016 |
|
Furosemide Injection 5%
RX
Furosemide
Liquid (Solution)
• Intravenous, Intramuscular
|
Elanco US Inc. | ANADA 200-293 | Approved | Jun 1, 2016 |
|
Furosemide Syrup 1%
RX
Furosemide
Syrup
• Oral
|
First Priority, Inc. | ANADA 200-373 | Approved | Jun 1, 2016 |
|
Furosemide Syrup 1%
RX
Furosemide
Liquid
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-382 | Approved | Jun 1, 2016 |
|
Furosemide Tablets
RX
Furosemide
|
Bolar Pharmaceutical Co., Inc. | NADA 125-329 | W | Jun 1, 2016 |
|
Furosemide Tablets
RX
Furosemide
Tablet
• Oral
|
Teva Animal Health, Inc. | NADA 131-806 | W | Jun 1, 2016 |
|
Lasix® Packets
RX
Furosemide
Powder
• Oral
|
Intervet, Inc. | NADA 45188 | Approved | Jun 1, 2016 |
|
Lasix® Syrup 1%
RX
Furosemide
Syrup
• Oral
|
Intervet, Inc. | NADA 102-380 | Approved | Jun 1, 2016 |
|
Salix® Tablets
RX
Furosemide
Tablet
• Oral
|
Intervet, Inc. | NADA 34621 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
1 to 2 mg/lb body weight (approximately 2.5 to 5 mg/kg). The lower dosage is suggested for cats. Administer once or twice daily at 6 to 8 hour intervals either orally, intravenously, or intramuscularly.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Indications: It is used for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
For treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
- Furosemide Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Salix® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Furos-A-Vet (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Disal® Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Disal® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Disal® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061739.pdf
Summary
Diuretic-saluretic for prompt relief of edema.
- Furosemide Injection 5% (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm059305.pdf
Summary
A diuretic-saluretic for oral use alone or in combination with Furosemide Injection in the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
- Furosemide Syrup 1% (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061337.pdf
Summary
A diuretic-saluretic for oral use alone or in combination with furosemide Injection in the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema.
- Furosemide Syrup 1% (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Furosemide Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Furosemide Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Lasix® Packets (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Lasix® Syrup 1% (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Salix® Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
Diuretic used to manage fluid overload (commonly in heart failure).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Use caution with dehydration, kidney disease, or electrolyte imbalances.
Side Effects
Increased urination, dehydration, electrolyte changes.
Source: FDA openFDA • Reference
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Showing top 5 for Digestive.
Showing top 5 for Neurologic.
Showing top 5 for Behavior.
Showing top 5 for Effectiveness.
Show more (16)
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Ragdoll, Female, 2 year, 4.3 kilogram • Drug: MSK, Oral, Dose: 1.14 Milligram per kilogram, Frequency: 12 per hour • Reactions: Cough • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-055590
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 2.00 Year
- Weight: 4.300 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Dose: 1.14 Milligram per kilogram
- Frequency: 12 per hour
Dog, Spitz - German Pomeranian, Male, 13 year, 7.257 kilogram • Drug: MSK, Tablet, Oral, Frequency: 1 per day • Reactions: Deafness, Sleepiness - systemic disorder, Not eating, Behavioral disorder (unspecified), Lack of efficacy - NOS • Outcome: Recovered with Sequela
- Report ID: USA-USFDACVM-2025-US-055953
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 13.00 Year
- Weight: 7.257 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Frequency: 1 per day
Dog, Chihuahua, Female, 12.2 year, 3.901 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Vomiting, Underdose, Hypothermia, Unsteady walking (ataxia), Dehydration… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054506
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 12.20 Year
- Weight: 3.901 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Unassigned
Cat, Domestic Shorthair, Male, 13 year, 6.804 kilogram • Drug: MSK, Unassigned, Intravenous, Dose: 1 Milligram per kilogram • Reactions: Nausea, Prolonged one stage prothrombin time, Prolonged activated partial thrombin time, Cardiac arrest, Death • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-055853
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 13.00 Year
- Weight: 6.804 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intravenous
- Form: Unassigned
- Dose: 1 Milligram per kilogram
Dog, Chihuahua, Male, 19 year, 3.13 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Overdose, Tiredness (lethargy) • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055295
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 19.00 Year
- Weight: 3.130 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Dog, Beagle, Male, 15 year, 12.61 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Cognitive disorder NOS, Pacing, Partial deafness, Impaired vision, Behavioral disorder (unspecified)… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054448
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 15.00 Year
- Weight: 12.610 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Dog, Retriever - Labrador, Female, 10 year, 24.63 kilogram • Drug: MSK • Reactions: Lack of efficacy (bacteria) - Anaplasma, Lack of efficacy (bacteria) - Borrelia • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055732
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 10.00 Year
- Weight: 24.630 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
Cat, Ragdoll, Female, 2 year, 4.3 kilogram • Drug: MSK, Oral, Dose: 1.14 Milligram per kilogram, Frequency: 12 per hour • Reactions: Foaming at the mouth • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-053844
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 2.00 Year
- Weight: 4.300 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Dose: 1.14 Milligram per kilogram
- Frequency: 12 per hour
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
Store at room temperature.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.